Medical Affairs

Medical Needs Are Learned on Site.
Offering True Value with Our Pharmaceutical Products

We proactively conduct various activities to accurately grasp the needs of patients, their families and healthcare professionals to execute medical communication and provision of medical information to address those needs in a scientifically objective, unbiased, reliable, and evidence-based manner.
The value of pharmaceuticals increases as post-marketing information (evidence) is accumulated and added to the compound information. The department constantly makes efforts to determine medical needs that are not adequately met for patients, their families and healthcare professionals, and engages in various evidence creating activities to fulfill these unmet needs. We believe that information based on the evidence we generate is essential because it will serve as a reassuring factor for healthcare professionals and help ensure appropriate treatment for the patients.

Medical Affairs Function

The Medical Affairs function operates based on voluntary standards issued by the Japan Pharmaceutical Manufacturers Association (JPMA)*1, such as “Consensus Statement on Medical Affairs Activities” and “Consensus Statement on Medical Science Liaison Activities.” To ensure that activities are independent of marketing and not conducted for the purpose of gaining sales of our pharmaceutical products, we endeavor to maximize their medical value for patients and healthcare professionals and promote their proper use. This is done by creating evidence through advanced medical and scientific exchanges with healthcare professionals and disseminating information based on it. Medical Science Liaison (MSL) strives to identify medical needs that lead to creating new evidence, additional formulations and expanding indications through scientific discussion with healthcare professionals, and provide high quality information in response to inquiries from them.

Medical Affairs Function

We are currently making efforts to promote medical activities such as evidence generation, provision, and dissemination primarily in the areas of psychiatry & neurology, diabetes, and oncology. The research outcomes obtained through evidence generation activities are disseminated to healthcare professionals through conference presentations and publication of papers*2. Additionally, we are actively engaged in database studies utilizing real-world data, which is widely utilized worldwide. By transparently publishing the results of these studies, we aim to contribute to the daily medical practices of healthcare professionals. Achieving the SDGs requires governments and other decision-makers to have access to necessary resources in all regions of the world and to invest their full efforts into scientific and technological innovations. We believe that by openly publishing research findings as open access papers as far as possible, we can contribute to the achievement of the SDGs.